MA37999A1 - Dérivés de macrolide, leur préparation et leur utilisation thérapeutique - Google Patents

Dérivés de macrolide, leur préparation et leur utilisation thérapeutique

Info

Publication number
MA37999A1
MA37999A1 MA37999A MA37999A MA37999A1 MA 37999 A1 MA37999 A1 MA 37999A1 MA 37999 A MA37999 A MA 37999A MA 37999 A MA37999 A MA 37999A MA 37999 A1 MA37999 A1 MA 37999A1
Authority
MA
Morocco
Prior art keywords
preparation
therapeutic use
macrolide derivatives
macrolide
derivatives
Prior art date
Application number
MA37999A
Other languages
English (en)
Other versions
MA37999B1 (fr
Inventor
Nicolas Baurin
Yannick Benedetti
Emmanuel Bouley
Jidong Zhang
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of MA37999A1 publication Critical patent/MA37999A1/fr
Publication of MA37999B1 publication Critical patent/MA37999B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

L'invention concerne des composés de formule (i) ci-dessous : formule (i), leur procédé de préparation et leur utilisation thérapeutique.
MA37999A 2012-09-18 2015-04-12 Dérivés de macrolide, leur préparation et leur utilisation thérapeutique MA37999B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1258744A FR2995605B1 (fr) 2012-09-18 2012-09-18 Derives de macrolides, leur preparation et leur application therapeutique.
PCT/EP2013/069185 WO2014044645A1 (fr) 2012-09-18 2013-09-16 Dérivés de macrolide, leur préparation et leur utilisation thérapeutique

Publications (2)

Publication Number Publication Date
MA37999A1 true MA37999A1 (fr) 2016-05-31
MA37999B1 MA37999B1 (fr) 2016-12-30

Family

ID=47178173

Family Applications (1)

Application Number Title Priority Date Filing Date
MA37999A MA37999B1 (fr) 2012-09-18 2015-04-12 Dérivés de macrolide, leur préparation et leur utilisation thérapeutique

Country Status (32)

Country Link
US (1) US20150210729A1 (fr)
EP (1) EP2897970B1 (fr)
JP (1) JP6231107B2 (fr)
KR (1) KR20150056569A (fr)
CN (1) CN104797588B (fr)
AU (1) AU2013320407A1 (fr)
BR (1) BR112015005560A2 (fr)
CA (1) CA2884909A1 (fr)
CL (1) CL2015000659A1 (fr)
CR (1) CR20150160A (fr)
DK (1) DK2897970T3 (fr)
DO (1) DOP2015000062A (fr)
EA (1) EA027177B1 (fr)
ES (1) ES2598079T3 (fr)
FR (1) FR2995605B1 (fr)
HK (1) HK1209127A1 (fr)
HR (1) HRP20161184T1 (fr)
HU (1) HUE029841T2 (fr)
IL (1) IL237593A (fr)
MA (1) MA37999B1 (fr)
MX (1) MX2015003503A (fr)
NZ (1) NZ706393A (fr)
PE (1) PE20150653A1 (fr)
PH (1) PH12015500527A1 (fr)
PL (1) PL2897970T3 (fr)
PT (1) PT2897970T (fr)
SG (1) SG11201501765YA (fr)
SI (1) SI2897970T1 (fr)
TN (1) TN2015000095A1 (fr)
UA (1) UA114003C2 (fr)
WO (1) WO2014044645A1 (fr)
ZA (1) ZA201501597B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019020763A1 (fr) 2017-07-26 2019-01-31 Sanofi Macrolides de séquanamycine utiles dans le traitement de la tuberculose
WO2019020767A1 (fr) 2017-07-26 2019-01-31 Sanofi Macrolides de séquanamycine utiles dans le traitement de la tuberculose
WO2019020759A1 (fr) 2017-07-26 2019-01-31 Sanofi Macrolides de séquanamycine utiles dans le traitement de la tuberculose

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3674773A (en) * 1970-10-06 1972-07-04 Abbott Lab Erythromycin derivatives
FR2126108B1 (fr) * 1971-02-25 1974-08-02 Rhone Poulenc Sa
CN85103264A (zh) * 1984-04-13 1987-01-14 美国辉瑞有限公司 9a-氮杂-9a-高红霉素衍生物
US4585759A (en) * 1985-01-22 1986-04-29 Pfizer Inc. Antibacterial derivatives of a neutral macrolide
CA1296329C (fr) * 1986-06-06 1992-02-25 Derek R. Sutherland Composes de type macrolide
US4920102A (en) * 1988-04-18 1990-04-24 Eli Lilly And Company Method for treating gastrointestinal disorders
JPH05117291A (ja) * 1991-09-20 1993-05-14 Yamanouchi Pharmaceut Co Ltd 新規マクロライド誘導体
TW226373B (fr) * 1992-07-15 1994-07-11 Pfizer
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
ES2243798T3 (es) * 2001-11-07 2005-12-01 Aventis Pharma Deutschland Gmbh Procedimiento para la produccion de desclaritromicina, asi como prodcutos intermedios.
GB0310980D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
CN101115764B (zh) * 2005-02-09 2012-09-26 巴斯利尔药物股份公司 大环内酯类化合物
TW200914020A (en) 2007-08-28 2009-04-01 Lilly Co Eli Substituted piperazinyl pyrazines and pyridines as 5-HT7 receptor antagonists

Also Published As

Publication number Publication date
CA2884909A1 (fr) 2014-03-27
TN2015000095A1 (en) 2016-06-29
CR20150160A (es) 2015-04-30
JP2015528485A (ja) 2015-09-28
UA114003C2 (xx) 2017-04-10
DK2897970T3 (en) 2016-11-07
ES2598079T3 (es) 2017-01-25
EA027177B1 (ru) 2017-06-30
EP2897970B1 (fr) 2016-07-13
HK1209127A1 (en) 2016-03-24
WO2014044645A1 (fr) 2014-03-27
US20150210729A1 (en) 2015-07-30
NZ706393A (en) 2018-07-27
SG11201501765YA (en) 2015-04-29
CN104797588B (zh) 2017-10-20
ZA201501597B (en) 2016-01-27
HUE029841T2 (en) 2017-04-28
EP2897970A1 (fr) 2015-07-29
MA37999B1 (fr) 2016-12-30
AU2013320407A1 (en) 2015-04-16
CL2015000659A1 (es) 2015-07-10
MX2015003503A (es) 2015-10-26
IL237593A (en) 2017-08-31
CN104797588A (zh) 2015-07-22
EA201590594A1 (ru) 2015-07-30
FR2995605B1 (fr) 2014-09-19
PH12015500527B1 (en) 2015-04-27
PL2897970T3 (pl) 2017-08-31
HRP20161184T1 (hr) 2016-11-04
DOP2015000062A (es) 2015-04-15
PT2897970T (pt) 2016-10-25
SI2897970T1 (sl) 2016-11-30
JP6231107B2 (ja) 2017-11-15
BR112015005560A2 (pt) 2017-07-04
FR2995605A1 (fr) 2014-03-21
IL237593A0 (en) 2015-04-30
PE20150653A1 (es) 2015-05-26
PH12015500527A1 (en) 2015-04-27
KR20150056569A (ko) 2015-05-26

Similar Documents

Publication Publication Date Title
MD4496B1 (ro) Analogi carba-nucleozidici 2'-substituiţi pentru tratament antiviral
MA32351B1 (fr) Derives d'aminodihydrothiazine a titre d'inhibiteurs de bace pour le traitement de la maladie d'alzheimer
MA37519A1 (fr) Composés et compositions pour inhiber l'activité d'abl1, abl2 et bcr-abl1
MA37405A1 (fr) Composés hétérocyclyle
BR112015028452A2 (pt) agonistas do receptor somastatina subtipo 4 (sstr4)
MA35841B1 (fr) Dérivés de pyrazolopyridine, procédé d'élaboration de ces dérivés, et utilisation thérapeutique de ceux-ci
EA201200176A1 (ru) Производные оксазина и их применение для лечения неврологических нарушений
MA37142A3 (fr) Dérivés de dihydro-benzo-oxazine et de dihydro-pyrido-oxazine
EA201500182A1 (ru) 4-МЕТИЛ-2,3,5,9,9b-ПЕНТААЗАЦИКЛОПЕНТА[a]НАФТАЛИНЫ
EA201400976A1 (ru) Бензодиоксаны в комбинации с другими активными средствами для ингибирования продуцирования лейкотриена
EA201491747A1 (ru) Замещенные пиридопиримидиновые соединения и их применение в качестве flt3 ингибиторов
MA37384B1 (fr) Nouveaux dérivés de thiénopyrimidine, leurs procédés de préparation et leurs utilisations thérapeutiques.
MA38803A1 (fr) Nouveaux dérivés d'indolizine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
MX2016007128A (es) Compuestos del receptor 6 de quimiocina (ccr6).
MA35816B1 (fr) Dérivés d'aniline, leur préparation et leur application thérapeutique
GEP20156315B (en) Oxazoline and isoxazoline derivatives as crac modulators
MA35196B1 (fr) Dérivés de 2-amino-3-(inidazol-2-yl)-pyridine-4-one et utilisation de ceux-ci comme inhibiteurs de kinases associées au récepteur du vegf
UA107455C2 (uk) Похідні індолу як протиракові агенти
MX2016006763A (es) Inhibidores de tirosina cinasa de bruton.
MX2016006744A (es) Inhibidores de tirosina cinasa de bruton.
MA35742B1 (fr) Dérivés de n- (4 -quinolinylmethyl) sulfonamide et leur utilisation en tant qu'antihelminthiques
MA37999B1 (fr) Dérivés de macrolide, leur préparation et leur utilisation thérapeutique
EA201600323A1 (ru) Производные пиперазина и их применение в качестве лекарственного средства
MX2016006351A (es) Inhibidores de tirosina cinasa de bruton.
MA38010B1 (fr) Dérivés d'éthynyl utilisés en tant que modulateurs de l'activité des récepteurs mglur5